22 May 2013
Keywords: ofatumumab, patients, reach, acr, uk, drug, major
Article | 25 June 2007
UK drug major GlaxoSmithKline and Denmark's Genmab AS reported positive primary efficacy data at the 2007 meeting of the European League ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
25 June 2007
21 May 2013
© 2013 thepharmaletter.com